Contrast induced nephropathy;Kontrastmittel-induzierte Nephropathie

Wiener Klinische Wochenschrift

Volumn 121, Issue 1-2, 2009, Pages 15-32

  Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute renal failure; Contrast media induced nephropathy; Hemodialysis; N acetylcystein; Sodium bicarbonate; Theophylline; Volume expansion

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BICARBONATE; CONTRAST MEDIUM; FENOLDOPAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTRAST INDUCED NEPHROPATHY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; DILUTION; DRUG COST; DRUG EFFICACY; FEEDBACK SYSTEM; FLUID INTAKE; GLOMERULUS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; HYDRATION; KIDNEY BLOOD VESSEL; MORTALITY; NEPHROTOXICITY; PROGNOSIS; PROPHYLAXIS; RENAL PROTECTION; REVIEW; RISK FACTOR; TREATMENT WITHDRAWAL; VASOCONSTRICTION;

ACETYLCYSTEINE; ALGORITHMS; CONTRAST MEDIA; CREATININE; FLUID THERAPY; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; OSMOLAR CONCENTRATION; RENAL DIALYSIS; RISK FACTORS; SODIUM BICARBONATE; THEOPHYLLINE;

EID: 62949170724     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-009-1145-3     Document Type: Review

References (125)

1. RW Katzberg 1997 Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity Radiology 204 2 297 312
2. EM Levy CM Viscoli RI Horwitz 1996 The effect of acute renal failure on mortality. A cohort analysis JAMA 275 19 1489 1494
3. G Dangas I Iakovou E Nikolsky ED Aymong GS Mintz NN Kipshidze AJ Lansky I Moussa GW Stone JW Moses MB Leon R Mehran 2005 Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables Am J Cardiol 95 1 13 19
4. R Mehran ED Aymong E Nikolsky Z Lasic I Iakovou M Fahy GS Mintz AJ Lansky JW Moses GW Stone MB Leon G Dangas 2004 A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 7 1393 1399
5. SD Weisbord H Chen RA Stone KE Kip MJ Fine MI Saul PM Palevsky 2006 Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography J Am Soc Nephrol 17 10 2871 2877
6. E Nikolsky R Mehran ED Aymong GS Mintz AJ Lansky Z Lasic M Negoita M Fahy SJ Pocock Y Na S Krieger JW Moses GW Stone MB Leon G Dangas 2004 Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions Am J Cardiol 94 8 1023 1027
7. E Nikolsky ED Aymong G Dangas R Mehran 2003 Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function Rev Cardiovasc Med 4 Suppl 1 S7 SS14
8. SD Weisbord PM Palevsky 2008 Prevention of contrast-induced nephropathy with volume expansion Clin J Am Soc Nephrol 3 1 273 280
9. RW Katzberg C Haller 2006 Contrast-induced nephrotoxicity: clinical landscape Kidney Int Suppl 100 S3 S7
10. PS Parfrey SM Griffiths BJ Barrett MD Paul M Genge J Withers N Farid PJ McManamon 1989 Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study N Engl J Med 320 3 143 149
11. CL Manske JM Sprafka JT Strony Y Wang 1990 Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography Am J Med 89 5 615 620
12. I Iakovou G Dangas R Mehran AJ Lansky DT Ashby M Fahy GS Mintz KM Kent AD Pichard LF Satler GW Stone MB Leon 2003 Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention J Invasive Cardiol 15 1 18 22
13. E Nikolsky R Mehran Z Lasic GS Mintz AJ Lansky Y Na S Pocock M Negoita I Moussa GW Stone JW Moses MB Leon G Dangas 2005 Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions Kidney Int 67 2 706 713
14. NV Guitterez A Diaz GC Timmis WW O'Neill MA Stevens KR Sandberg PA McCullough 2002 Determinants of serum creatinine trajectory in acute contrast nephropathy J Interv Cardiol 15 15 349 354
15. HS Thomsen 2005 How to avoid CIN: guidelines from the European Society of Urogenital Radiology Nephrol Dial Transplant 20 Suppl 1 i18 i22
16. R Mehran E Nikolsky 2006 Contrast-induced nephropathy: definition, epidemiology, and patients at risk Kidney Int 100 S11 S15
17. KA Sterling T Tehrani MR Rudnick 2008 Clinical significance and preventive strategies for contrast-induced nephropathy Curr Opin Nephrol Hypertens 17 6 616 623
18. D Russo R Minutolo B Cianciaruso B Memoli G Conte L De Nicola 1995 Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure J Am Soc Nephrol 6 5 1451 1458
19. JA Tumlin A Wang PT Murray VS Mathur 2002 Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy Am Heart J 143 5 894 903
20. SS Brar AY Shen MB Jorgensen A Kotlewski VJ Aharonian N Desai M Ree AI Shah RJ Burchette 2008 Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial JAMA 300 9 1038 1046
21. G Tavernier G Toumaniantz M Erfanian MF Heymann K Laurent D Langin C Gauthier 2008 beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor Cardiovasc Res 59 2 288 296
22. PA McCullough R Wolyn LL Rocher RN Levin WW O'Neill 1997 Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 5 368 375
23. L Gruberg GS Mintz R Mehran G Gangas AJ Lansky KM Kent AD Pichard LF Satler MB Leon 2000 The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency J Am Coll Cardiol 36 5 1542 1548
24. CS Rihal SC Textor DE Grill PB Berger HH Ting PJ Best M Singh MR Bell GW Barsness V Mathew KN Garratt DR Holmes Jr 2002 Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 19 2259 2264
25. A Bouzas-Mosquera JM Vázquez-Rodríguez R Calviño-Santos J Peteiro-Vázquez X Flores-Ríos R Marzoa-Rivas P Piñón-Esteban G Aldama-López J Salgado-Fernández N Vázquez-González A Castro-Beiras 2007 Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis Rev Esp Cardiol 60 10 1026 1034
26. AM From BJ Bartholmai AW Williams SS Cha FS McDonald 2008 Mortality associated with nephropathy after radiographic contrast exposure Mayo Clin Proc 83 10 1095 1100
27. M Rudnick H Feldman 2008 Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 3 1 263 272
28. L Gruberg R Mehran G Dangas GS Mintz R Waksman KM Kent AD Pichard LF Satler H Wu MB Leon 2001 Acute renal failure requiring dialysis after percutaneous coronary interventions Catheter Cardiovasc Interv 52 4 409 416
29. C Davidson F Stacul PA McCullough J Tumlin A Adam N Lameire CR Becker CIN Consensus Working Panel 2006 Contrast medium use Am J Cardiol 98 6A 42K 58K
30. PA McCullough F Stacul CR Becker A Adam N Lameire JA Tumlin CJ Davidson CIN Consensus Working Panel 2006 Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary Rev Cardiovasc Med 7 4 177 197
31. SE Miner V Dzavik P Nguyen-Ho R Richardson J Mitchell D Atchison P Seidelin P Daly J Ross PR McLaughlin D Ing P Lewycky A Barolet L Schwartz 2004 N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up Am Heart J 148 4 690 695
32. B Hölscher C Heitmeyer M Fobker G Breithardt RM Schaefer H Reinecke 2008 Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus- Diuresis (DVD) trial Can J Cardiol 24 11 845 850
33. R Solomon C Werner D Mann J D'Elia P Silva 1994 Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 21 1416 1420
34. HS Trivedi H Moore S Nasr K Aggarwal A Agrawal P Goel J Hewett 2003 A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity Nephron Clin Pract 93 1 C29 C34
35. AJ Taylor D Hotchkiss RW Morse J McCabe 1998 PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction Chest 114 6 1570 1574
36. BD Bader ED Berger MB Heede I Silberbaur S Duda T Risler CM Erley 2004 What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62 1 1 7
37. MA Stevens PA McCullough KJ Tobin JP Speck DC Westveer DA Guido-Allen GC Timmis WW O'Neill 1999 A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation J Am Coll Cardiol 33 2 403 411
38. B Dussol S Morange A Loundoun P Auquier Y Berland 2006 A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients Nephrol Dial Transpl 21 8 2120 2126
39. N Mueller-Lenke G Buerkle T Klima T Breidthardt HJ Buettner C Mueller 2008 Incidence of contrast-induced nephropathy with volume supplementation- insights from a large cohort Med Princ Pract 17 5 409 414
40. SD Weisbord MK Mor AL Resnick KC Hartwig AF Sonel MJ Fine PM Palevsky 2008 Prevention, incidence, and outcomes of contrast-induced acute kidney injury Arch Intern Med 168 12 1325 1332
41. C Mueller G Buerkle HJ Buettner J Petersen AP Perruchoud U Eriksson S Marsch H Roskamm 2002 Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty Arch Intern Med 126 3 329 336
42. GJ Merten WP Burgess LV Gray JH Holleman TS Roush GJ Kowalchuk RM Bersin A Van Moore CA Simonton 3rd RA Rittase HJ Norton TP Kennedy 2004 Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 19 2328 2334
43. EE Ozcan S Guneri B Akdeniz IZ Akyildiz O Senaslan N Baris O Aslan O Badak 2007 Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial Am Heart J 154 3 539 544
44. C Briguori F Airoldi D D'Andrea E Bonizzoni N Morici A Focaccio I Michev M Montorfano M Carlino J Cosgrave B Ricciardelli A Colombo 2007 Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies Circulation 115 10 1211 1217
45. M Masuda T Yamada T Mine T Morita S Tamaki Y Tsukamoto K Okuda Y Iwasaki M Hori M Fukunami 2007 Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure Am J Cardiol 100 5 781 786
46. A Recio-Mayoral M Chaparro B Prado R Cózar I Méndez D Banerjee JC Kaski J Cubero JM Cruz 2007 The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study J Am Coll Cardiol 49 12 1283 1288
47. AM From BJ Bartholmai AW Williams SS Cha A Pflueger FS McDonald 2008 Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic Clin J Am Soc Nephrol 3 1 10 18
48. M Maioli A Toso M Leoncini M Gallopin D Tedeschi C Micheletti F Bellandi 2008 Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention J Am Coll Cardiol 52 8 599 604
49. P Schmidt D Pang D Nykamp G Knowlton H Jia 2007 N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography Ann Pharmacother 41 1 46 50
50. E Adolph B Holdt-Lehmann T Chatterjee S Paschka A Prott H Schneider T Koerber H Ince M Steiner P Schuff-Werner CA Nienaber 2008 Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy Coron Artery Dis 19 6 413 419
51. SE Hogan P L'Allier S Chetcuti PM Grossman BK Nallamothu C Duvernoy E Bates M Moscucci HS Gurm 2008 Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis Am Heart J 156 3 414 421
52. M Joannidis M Schmid CJ Wiedermann 2008 Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis Wien Klin Wochenschr 120 23-24 742 748
53. M Masuda T Yamada Y Okuyama T Morita S Sanada Y Furukawa Y Tsukamoto K Okuda Y Iwasaki T Yasui M Fukunami 2008 Sodium bicarbonate improves long-term clinical outcomes compared with sodium chloride in patients with chronic kidney disease undergoing an emergent coronary procedure Circ J 72 10 1610 1614
54. K Spargias E Alexopoulos S Kyrzopoulos P Iokovis DC Greenwood A Manginas V Voudris G Pavlides CE Buller D Kremastinos DV Cokkinos 2004 Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Circulation 110 18 2837 2842
55. A Boscheri C Weinbrenner B Botzek K Reynen E Kuhlisch RH Strasser 2007 Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction Clin Nephrol 68 5 279 286
56. S Fishbane 2008 N-acetylcysteine in the prevention of contrast-induced nephropathy Clin J Am Soc Nephrol 3 1 281 287
57. DA Stenstrom LL Muldoon H Armijo-Medina S Watnick ND Doolittle JA Kaufman DR Peterson J Bubalo EA Neuwelt 2008 N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials J Vasc Interv Radiol 19 3 309 318
58. M Tepel M van der Giet C Schwarzfeld U Laufer D Liermann W Zidek 2000 Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 3 180 184
59. C Briguori A Colombo A Violante P Balestrieri F Manganelli P Paolo Elia B Golia S Lepore G Riviezzo P Scarpato A Focaccio M Librera E Bonizzoni B Ricciardelli 2004 Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity Eur Heart J 25 3 206 211
60. G Marenzi E Assanelli I Marana G Lauri J Campodonico M Grazi M De Metrio S Galli F Fabbiocchi P Montorsi F Veglia AL Bartorelli 2006 N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 26 2773 2782
61. R Birck S Krzossok F Markowetz P Schnülle FJ van der Woude C Braun 2003 Acetylcysteine for prevention of contrast nephropathy: meta-analysis Lancet 362 9384 598 603
62. N Pannu B Manns H Lee M Tonelli 2004 Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 4 1366 1374
63. BK Nallamothu KG Shojania S Saint TP Hofer HD Humes M Moscucci ER Bates 2004 Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis Am J Med 117 12 938 947
64. DA Gonzales KJ Norsworthy SJ Kern S Banks PC Sieving RA Star C Natanson RL Danner 2007 A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity BMC Med 14 5 32
65. A Alonso J Lau BL Jaber A Weintraub MJ Sarnak 2004 Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials Am J Kidney Dis 43 1 1 9
66. AV Kshirsagar C Poole A Mottl D Shoham N Franceschini G Tudor M Agrawal C Denu-Ciocca E Magnus Ohman WF Finn 2004 N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials J Am Soc Nephrol 15 3 761 769
67. DW Isenbarger SM Kent PG O'Malley 2004 Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy Am J Cardiol 92 12 1454 1458
68. AM Kelly B Dwamena P Cronin SJ Bernstein RC Carlos 2008 Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 4 284 294
69. AI Spielman LJ Arend 1991 Adenosine receptors and signaling in the kidney Hypertension 17 2 117 130
70. K Arakawa H Suzuki M Naitoh A Matsumoto K Hayashi H Matsuda A Ichihara E Kubota T Saruta 1996 Role of adenosine in the renal responses to contrast medium Kidney Int 49 5 1199 1206
71. LJ Arend GL Bakris JC Burnett Jr C Megerian WS Spielman 1987 Role for intrarenal adenosine in the renal hemodynamic response to contrast media J Lab Clin Med 110 4 406 411
72. G Deray F Martinez P Cacoub B Baumelou A Baumelou C Jacobs 1990 A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction Am J Nephrol 10 4 316 322
73. SD Oldroyd L Fang JL Haylor MS Yates AM El Nahas SK Morcos 2000 Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney Clin Sci (London) 98 3 303 311
74. JH Ix CE McCulloch GM Chertow 2004 Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis Nephrol Dial Transplant 19 11 2747 2753
75. SM Bagshaw WA Ghali 2005 Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis Arch Intern Med 165 10 1087 1093
76. W Huber F Eckel M Hennig H Rosenbrock A Wacker D Saur A Sennefelder R Hennico C Schenk A Meining R Schmelz R Fritsch W Weiss P Hamar U Heemann RM Schmid 2006 Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study Radiology 239 3 793 804
77. JT Van Praet AS De Vriese 2007 Prevention of contrast-induced nephropathy: a critical review Curr Opin Nephrol Hypertens 16 4 336 347
78. G Landoni GG Biondi-Zoccai G Marino T Bove O Fochi G Maj MG Calabrò I Sheiban JA Tumlin M Ranucci A Zangrillo 2008 Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis J Cardiothorac Vasc Anesth 22 1 27 33
79. MK Ng J Tremmel PJ Fitzgerald WF Fearon 2006 Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy J Interven Cardiol 19 1 75 79
80. G Patti A Nusca M Chello V Pasceri A D'Ambrosio GW Vetrovec G Di Sciascio 2008 Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention Am J Cardiol 101 3 279 285
81. N Attallah L Yassine J Musial J Yee K Fisher 2004 The potential role of statins in contrast nephropathy Clin Nephrol 62 4 273 278
82. S Khanal N Attallah DE Smith E Kline-Rogers D Share MJ O'Donnell M Moscucci 2005 Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions Am J Med 118 8 843 849
83. SH Jo BK Koo JS Park HJ Kang YS Cho YJ Kim TJ Youn WY Chung IH Chae DJ Choi DW Sohn BH Oh YB Park YS Choi HS Kim 2008 Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - a randomized controlled study Am Heart J 155 3 499.e1 499.e8
84. Y Yokomaku T Sugimoto S Kume S Araki K Isshiki M Chin-Kanasaki M Sakaguchi N Nitta M Haneda D Koya T Uzu A Kashiwagi 2008 Asialoerythropoietin prevents contrast-induced nephropathy J Am Soc Nephrol 19 2 321 328
85. AY Kolyada O Liangos NE Madias BL Jaber 2008 Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury Am J Nephrol 28 2 203 208
86. WK Laskey C Jenkins F Selzer OC Marroquin RL Wilensky R Glaser HA Cohen DR Holmes Jr NHLBI Dynamic Registry Investigators 2007 Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention J Am Coll Cardiol 50 7 584 590
87. GC Kane BJ Doyle A Lerman GW Barsness PJ Best CS Rihal 2008 Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography J Am Coll Cardiol 51 1 89 90
88. M El-Hajjar I Bashir M Khan J Min M Torosoff A DeLago 2008 Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures Am J Cardiol 102 3 353 356
89. MC Heinrich L Häberle V Müller W Bautz M Uder 2009 Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials Radiology 250 1 68 86
90. MR Rudnick S Goldfarb L Wexler PA Ludbrook MJ Murphy EF Halpern JA Hill M Winniford MB Cohen DB Van-Fossen 1995 Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney Int 47 1 254 261
91. BJ Barrett EJ Carlisle 1993 Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 1 171 178
92. P Aspelin P Aubry SG Fransson R Strasser R Willenbrock KJ Berg Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators 2003 Nephrotoxic effects in high-risk patients undergoing angiography N Engl J Med 348 6 491 499
93. P Liss PB Persson P Hansell B Lagerqvist 2006 Renal failure in 57. 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media Kidney Int 70 10 1811 1817
94. PA McCullough ME Bertrand JA Brinker F Stacul 2006 A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media J Am Coll Cardiol 48 4 692 699
95. SH Jo TJ Youn BK Koo JS Park HJ Kang YS Cho WY Chung GW Joo IH Chae DJ Choi BH Oh MM Lee YB Park HS Kim 2006 Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial J Am Coll Cardiol 48 5 924 930
96. JL Anderson CD Adams EM Antman CR Bridges RM Califf DE Casey Jr WE Chavey 2nd FM Fesmire JS Hochman TN Levin AM Lincoff ED Peterson P Theroux NK Wenger RS Wright SC Smith Jr AK Jacobs CD Adams JL Anderson EM Antman JL Halperin SA Hunt HM Krumholz FG Kushner BW Lytle R Nishimura JP Ornato RL Page B Riegel American College of Cardiology American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) American College of Emergency Physicians Society for Cardiovascular Angiography and Interventions Society of Thoracic Surgeons American Association of Cardiovascular and Pulmonary Rehabilitation Society for Academic Emergency Medicine 2007 ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 7 e1 e157
97. RJ Solomon MK Natarajan S Doucet SK Sharma CS Staniloae RE Katholi JL Gelormini M Labinaz AE Moreyra Investigators of the CARE Study 2007 Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease Circulation 115 25 3189 3196
98. MR Rudnick C Davidson W Laskey JL Stafford PF Sherwin VALOR Trial Investigators 2008 Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial Am Heart J 156 4 776 782
99. MJ Kuhn N Chen DV Sahani D Reimer EJ van Beek JP Heiken GJ So 2008 The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure AJR Am J Roentgenol 191 1 151 157
100. BJ Barrett RW Katzberg HS Thomsen N Chen D Sahani G Soulez JP Heiken L Lepanto ZH Ni ZH Ni R Nelson 2006 Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol Invest Radiol 41 11 815 821
101. E Seeliger B Flemming T Wronski M Ladwig K Arakelyan M Godes M Möckel PB Persson 2007 Viscosity of contrast media perturbs renal hemodynamics J Am Soc Nephrol 18 11 2912 2920
102. G Romano C Briguori C Quintavalle C Zanca NV Rivera A Colombo G Condorelli 2008 Contrast agents and renal cell apoptosis Eur Heart J 29 20 2569 2576
103. RW Katzberg BJ Barrett 2007 Risk of iodinated contrast material - induced nephropathy with intravenous administration Radiology 243 3 622 628
104. RD Moore EP Steinberg NR Powe JA Brinker EK Fishman S Graziano R Gopalan 1992 Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial Radiology 182 3 649 655
105. BJ Barrett PS Parfrey HM Vavasour J McDonald G Kent D Hefferton F O'Dea E Stone R Reddy PJ McManamon 1992 Contrast nephropathy in patients with impaired renal function: high versus low osmolar media Kidney Int 41 5 1274 1279
106. EC Keeley CL Grines 1998 Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases J Am Coll Cardiol 32 7 1861 1865
107. G Ramirez WM O'Neill Jr R Lambert HA Bloomer 1978 Cholesterol embolization: a complication of angiography Arch Intern Med 138 1430 1432
108. T Lehnert E Keller K Gondolf T Schäffner H Pavenstädt P Schollmeyer 1998 Effect of haemodialysis after contrast medium administration in patients with renal insufficiency Nephrol Dial Transplant 13 2 358 362
109. B Vogt P Ferrari C Schönholzer HP Marti M Mohaupt M Wiederkehr C Cereghetti A Serra U Huynh-Do D Uehlinger FJ Frey 2001 Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful Am J Med 111 9 692 698
110. H Frank D Werner V Lorusso L Klinghammer WG Daniel U Kunzendorf J Ludwig 2003 Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure Clin Nephrol 60 3 176 182
111. H Reinecke M Fobker J Wellmann B Becke J Fleiter C Heitmeyer G Breithardt HW Hense RM Schaefer 2007 A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial Clin Res Cardiol 96 3 130 139
112. PT Lee KJ Chou CP Liu GY Mar CL Chen CY Hsu HC Fang HM Chung 2007 Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial J Am Coll Cardiol 50 11 1015 1020
113. G Marenzi I Marana G Lauri E Assanelli M Grazi J Campodonico D Trabattoni F Fabbiocchi P Montorsi AL Bartorelli 2003 The prevention of radiocontrast-agent-induced nephropathy by hemofiltration N Engl J Med 349 14 1333 1340
114. G Deray 2006 Dialysis and iodinated contrast media Kidney Int 100 Suppl S25 S29
115. M Tepel 2008 Does prophylactic haemodialysis protect kidney function after angiography? Nephrol Dial Transplant 23 11 3605 3612
116. J Newhouse D Kho QA Rao J Starren 2008 Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity AJR Am J Roentgenol 191 2 376 382
117. DA Baumgarten JH Ellis 2008 Contrast-induced nephropathy: Contrast material not required? AJR Am J Roentgenol 191 2 383 386
118. BJ Barrett PS Parfrey 2006 Clinical practice. Preventing nephropathy induced by contrast medium N Engl J Med 354 4 379 386
119. HS Thomsen SK Morcos BJ Barrett 2008 Contrast-induced nephropathy: the wheel has turned 360 degrees Acta Radiol 49 6 646 657
120. PA McCullough 2008 Contrast-induced acute kidney injury J Am Coll Cardiol 51 15 1419 1428
121. MA Onuigbo NT Onuigbo 2008 Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study Ren Fail 30 1 67 72
122. P Komenda N Zalunardo S Burnett J Love C Buller P Taylor J Duncan O Djurdjev A Levin 2007 Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series Clin Exp Nephrol 11 3 209 213
123. JL Rosenstock R Bruno JK Kim L Lubarsky R Schaller G Panagopoulos MV DeVita MF Michelis 2008 The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy Int Urol Nephrol 40 3 749 755
124. MR Rudnick S Goldfarb J Tumlin 2008 Contrast-induced nephropathy: is the picture and clearer? Clin J Am Soc Nephrol 3 1 261 262
125. PA McCullough 2008 Radiocontrast-induced acute kidney injury Nephron Physiol 109 4 61 72